Short answer
CVS Health (CVS) filed its Q2 2026 10-Q quarterly report on Aug 5, 2026 for the quarter ended Jun 30, 2026. Quarterly revenue was $106.1B (up 7.3% year over year) with net income of $3.0B.
Q2 2026 key financials · XBRL
- Revenue
- $106.1B
- +7.3% YoY · +5.6% QoQ
- Net income
- $3.0B
- +191.8% YoY · +1.2% QoQ
- Operating margin
- 4.4%
- EPS (diluted)
- $2.31
- +188.8% YoY · +0.4% QoQ
Source: XBRL data from the CVS Health (CVS) Q2 2026 10-Q on SEC EDGAR. USD.
CVS Health Q2 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Revenue, YoY change, profitability margins, and segment performance not provided
- Cash position, operating cash flow, and capital deployment figures not provided
Risk Factors
- No Risk Factors section provided; text covers stock repurchases under Item 2(c)
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other CVS Health quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.